Actions on Business Software and Cloud Services Through UK Digital Markets Competition Regime

The Competition and Markets Authority (CMA) published its final package of actions and remedies on business software and cloud services through the UK digital markets competition regime on 31 March 2026. The guidance applies to designated technology firms operating in UK business software and cloud markets. This establishes new competitive requirements that affected platforms must implement.

EDPB Coordinated Enforcement Framework 2026 Transparency Action

The European Data Protection Board (EDPB) launched its 2026 Coordinated Enforcement Framework (CEF) action, focusing on compliance with GDPR transparency and information obligations under Articles 12, 13, and 14. Twenty-five Data Protection Authorities (DPAs) across Europe will conduct enforcement actions and fact-finding exercises targeting data controllers from various sectors throughout 2026, with findings to be consolidated in an EDPB report and followed by targeted enforcement at national and EU levels.

EU notice for Iran restrictive measures data subjects

EU notice for Iran restrictive measures data subjects

Sigmon civil case dismissed Fourth Circuit appeal

Sigmon civil case dismissed Fourth Circuit appeal

United States v. Helton - Supervised Release Modification Appeal

The Fourth Circuit affirmed the district court's orders denying Steven Russell Helton's motions to modify conditions of his supervised release under 18 U.S.C. § 3583(e)(2). The appeals (Nos. 24-4366 and 25-4014) were consolidated and decided in favor of the government. No abuse of discretion was found in the district court's denial of Helton's modification requests.

Stevens v. North Carolina - Habeas Corpus Appeal

The Fourth Circuit dismissed petitioner Claude Mordecia Stevens' appeal seeking to challenge the district court's denial of his 28 U.S.C. § 2254 habeas petition. The court denied a certificate of appealability and dismissed the appeal, finding Stevens failed to demonstrate that reasonable jurists would find the district court's assessment of his constitutional claims debatable or wrong.

Data Reconstruction Using Machine-Learning Predictive Coding

USPTO published patent application US20260087314A1 for a machine-learning method that reconstructs data samples in a time series using predictive coding. The method generates reconstructed versions of first and second data samples, then uses a neural network to predict intermediate data samples positioned between them. The application (No. 19107781) was filed July 27, 2023 and published March 26, 2026.

Controlling Agents Using Ambiguity-Sensitive Neural Networks and Risk-Sensitive Neural Networks

USPTO published patent application US20260087311A1 for methods controlling AI agents using ambiguity-sensitive and risk-sensitive neural networks. The application covers action selection systems for agent control with four named inventors. Patent application was filed September 8, 2023, and published March 26, 2026.

Deepfake Music Detection Apparatus Using AI Classification

The USPTO published patent application US20260087313A1 for BRAINDECK INC. on March 26, 2026, covering an AI-based apparatus and method for detecting deepfake music. The system analyzes audio features, voice separation probability, and neural vocoder usage to determine whether audio content is synthetically generated. Application No. 18929273 was filed on October 28, 2024.

Combined Deep Learning Inference and Compression Using Sensed Data

USPTO published patent application US20260087312A1 for a device and method combining deep learning inference with data compression using sensed data. The system encodes sensed data locally, transmits it in batches to a remote computing system, and receives optimized encoder and prediction models in return. Inventors: Damian Kelly, Megan O'Brien, Gregory Buckley, Colleen B. Caveney.

Quantum-Capacitance Simulation Using Gaussian Subspace Aggregation

The USPTO published Microsoft Technology Licensing's patent application US20260087390A1 for a quantum-capacitance simulation method using Gaussian-subspace aggregation. The method constructs and projects non-interacting Hamiltonians for material configurations, then uses sums-of-Gaussians procedures to approximate low-energy eigenstates under interacting Hamiltonians. Inventors are Samuel Boutin and Roman Bela Bauer.

Fault Tolerant Quantum Computation via Logical Operators Measurement

USPTO published patent application US20260087389A1 by inventors Theodore James Yoder and Dominic Williamson disclosing systems and methods for low-overhead fault-tolerant quantum computation via measurement of logical operators. The invention utilizes a graph selection component to select an auxiliary graph and a measurement component to execute a deformed quantum stabilizer code on a quantum system. This patent has applications in quantum computing hardware and software development.

Transactional Neural Reasoning AI (TNRAI) Patent Application

USPTO published patent application US20260087387A1 for Transactional Neural Reasoning AI (TNRAI), a novel AI system designed for complex decision-making. The application describes a five-pillar architecture including delta-path modeling, skew-based adversarial recognition, vector memory recall, ambient reasoning overlays, and a multi-logic arbitration engine. Filed by inventor Joshua B. Williamson under application number 19171498.

US patent for cached MoE experts, Mar 26

US patent for cached MoE experts, Mar 26

Anthony Graham habeas corpus appeal denied, Minnesota Court affirms 30th Mar

Anthony Graham habeas corpus appeal denied, Minnesota Court affirms 30th Mar

Benga v. Allina Health - Medical Malpractice / Expert Testimony Exclusion

The Minnesota Court of Appeals reversed summary judgment and remanded a medical malpractice case (A25-0526) against Allina Health System, finding the district court erred in excluding expert testimony under Minnesota Rule of Evidence 702. The case involves a child who suffered permanent brachial plexus injuries during a shoulder dystocia delivery in November 2020. The appellate court determined the excluded expert testimony was necessary to establish the standard of care and causation.

State v. Anthony Richard Wiley - Attorney Disqualification

The Minnesota Court of Appeals affirmed the district court's disqualification of defense attorney Sarah M. Kyte in State v. Wiley (A25-1057). The court held that under Minnesota Rule of Professional Conduct 3.7(a), Kyte was properly disqualified because she would be a necessary witness regarding a phone conversation she conducted with a potential witness (C.P.) in the defendant's DWI case. The appellate court found no abuse of discretion in the district court's ruling.

State v. Kreckow - Blood Test Suppression Appeal

The Minnesota Court of Appeals affirmed the district court's denial of a motion to suppress blood-test evidence in a fourth-degree DWI case. The appellate court rejected appellant's argument that Minn. Stat. § 169A.51, subd. 4 required additional statutory steps before obtaining a blood-test warrant. Appellant Tashawn Markus Kreckow was found guilty based on a blood alcohol concentration of 0.102. This nonprecedential opinion clarifies warrant procedures for blood tests in impaired driving cases.

Trademark Application 87951847 - Computer Hardware and Telecommunications

The USPTO issued a trademark registration record for Application No. 87951847, an Intent to Use application covering computer hardware, integrated circuits, semiconductor chips, and telecommunications equipment. The application was filed on June 7, 2018, and covers goods including electronic components, telecommunications devices, and related software for mobile communication devices.

Intent to Use Trademark Application for Abstract Enterprise Software

USPTO received an Intent to Use trademark application (TM87498540) for "Abstract" covering enterprise computer software for monitoring, measuring, analyzing, and helping to improve sales effectiveness. The application was filed on June 21, 2017.

Vehicle Control Services Ltd v Ozog - Parking Charge Contract Dispute

The County Court at Wakefield dismissed Vehicle Control Services Ltd's appeal against a lower court ruling that no contract was formed when the defendant stopped his vehicle in a prohibited zone at Leeds Bradford Airport. The appellant sought £100 and £70 contractual charges; the court upheld the finding that the signage did not create binding contractual obligations. The defendant did not appear at the appeal hearing.

R v Spriddell - Costs Certification Application

England and Wales High Court (Senior Courts Costs Office) issued decision [2026] EWHC 567 (SCCO) on 12 March 2026, dismissing Mr David Spriddell's application to certify a point of principle of general importance regarding costs assessment under Regulation 11 of the Costs in Criminal Cases (General) Regulations 1986. Costs Judge Leonard declined certification following dismissal of the applicant's appeal against the Legal Aid Agency's redetermination of defendant's costs order.

Alphabet UK Ltd v AXA Insurance UK PLC - Costs Dispute

The England and Wales High Court (Senior Courts Costs Office) issued a costs judgment in the case of Alphabet (UK) Ltd v AXA Insurance UK PLC on 23 March 2026. The dispute concerned costs arising from a vehicle damage claim where the claimant, a BMW Group vehicle leasing company, pursued the defendant insurer directly under the European Communities (Rights Against Insurers) Regulation 2002 following a written-off van. Costs Judge Brown determined the costs order issue.

Laing O'Rourke Delivery Ltd v Shepperton Studios Ltd - Interest and Costs Judgment

The England and Wales High Court (TCC) issued a judgment in Laing O'Rourke Delivery Ltd v Shepperton Studios Ltd, determining that interest on contractual sums should be calculated by including VAT as part of the contract price per the parties' contractual provisions. The Court departed from the adjudicator's approach as both parties requested review, resulting in a total sum due of £3,838,392.77 including interest from 22 August 2025 to 16 March 2026. The judgment aligns with the earlier Pharos Offshore v Kenvor Morlift decision on VAT-inclusive interest calculations.

DailyGobble Inc v Jain - Cross-Border Evidence Gathering Costs

The England and Wales High Court issued a costs judgment in DailyGobble Inc v Jain, a case arising from cross-border evidence gathering under the Hague Convention 1970 and the Evidence (Proceedings in Other Jurisdictions) Act 1975. The court determined costs allocation between the parties following their agreement on substantive disclosure and examination dates in pending US litigation before the Superior Court of California.

Currie v Soho Theatre Company Ltd - Libel Appeal on Meaning

The England and Wales Court of Appeal (Civil Division) dismissed an appeal by comedian Paul Currie challenging the High Court's determination of the natural and ordinary meaning of a Soho Theatre press release dated 13 February 2024. The press release described alleged antisemitic conduct during Currie's performance. The Court upheld the Judge's findings on the preliminary issue of meaning under Case No CA-2025-000974.

Scheduled Banks Statement of Position in India

The Reserve Bank of India released the scheduled banks' statement of position as of March 15, 2026, providing statistical data on liabilities and assets of scheduled commercial banks (including RRBs, SFBs, and PBs). The release contains comparative figures from March 21, 2025, and February 28, 2026, for liabilities including deposits from banks and others, borrowings, and other demand and time liabilities.

RBI February 2026 Sectoral Bank Credit Data

RBI released February 2026 sectoral bank credit data showing 14.3% year-on-year growth in non-food bank credit, up from 11.1% in the corresponding period last year. Credit to agriculture grew 12.3%, industry credit increased 13.5%, services sector credit rose 16.3%, and personal loans expanded 15.2%. The data covers 41 scheduled commercial banks accounting for approximately 95% of total non-food credit.

India International Investment Position Q4 2025

The Reserve Bank of India released Q4 2025 International Investment Position data showing India's net claims of non-residents declined by $10.9 billion to $260.5 billion. The assets-to-liabilities ratio improved to 82.1% from 81.4% in Q3 2025 and 74.6% a year ago, while reserve assets stood at $687.7 billion.

Monthly Data on India International Trade in Services February 2026

The Reserve Bank of India released provisional monthly data on India's international trade in services for February 2026. Services exports (receipts) were valued at US$ 34,708 million, representing a decline of 2.1% year-over-year, while services imports (payments) stood at US$ 16,865 million. The data for January-February 2026 remains provisional, while figures for October-December 2025 have been revised based on updated balance of payments statistics.

Supervisory Data Quality Index for Scheduled Commercial Banks

The Reserve Bank of India released the Supervisory Data Quality Index (sDQI) for Scheduled Commercial Banks covering December 2025. The index measures data quality through four dimensions: Accuracy, Timeliness, Completeness, and Consistency in supervisory return submissions. It assesses bank adherence to the Master Direction on Filing of Supervisory Returns 2024.

Result of Second 3-Day Variable Rate Repo Auction - March 2026

The Reserve Bank of India conducted a 3-day Variable Rate Repo (VRR) auction on March 30, 2026, allotting ₹34,581 crore against a notified amount of ₹50,000 crore. The cut-off rate was 5.26% with a weighted average rate of 5.30%. This is a routine monetary policy operation conducted by the RBI to manage short-term liquidity in the banking system.

Taxation (Multinational—Global and Domestic Minimum Tax) Rules 2024

The Australian Treasury has issued legislative rules implementing the OECD Pillar Two Global Minimum Tax framework, establishing Income Inclusion Rule (IIR) and Domestic Top-up Tax mechanisms. The rules apply to multinational enterprise groups with consolidated revenue of at least €750 million and impose top-up tax liabilities where foreign jurisdictions apply an effective tax rate below 15% on a jurisdictional basis.

Pharmaceutical Benefits Scheme April Update

The Department of Health, Disability and Ageing issued Instrument F2026L00408 amending the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 (PB 26 of 2024). This quarterly PBS update modifies pharmaceutical benefit listings under the National Health Act 1953. The instrument takes effect on 31 March 2026.

Highly Specialised Drugs Program Amendment

The Australian Department of Health and Aged Care issued Legislative Instrument F2026L00403 amending the National Health (Highly Specialised Drugs Program) Special Arrangement 2021 (PB 27 of 2021). This April update modifies Schedule 1 of the existing special arrangement governing highly specialised drugs access under the Pharmaceutical Benefits Scheme. The amendment takes effect on 31 March 2026 and is authorised under the National Health Act 1953.

IVF Program Special Arrangement Amendment

The Australian Department of Health and Aged Care issued Instrument F2026L00409 amending the National Health (IVF Program) Special Arrangement 2025 under the National Health Act 1953. This amendment updates the regulatory framework governing the Medicare-funded IVF treatment program, affecting healthcare providers delivering fertility services and patients seeking assisted reproductive technology treatments.

Diaminoguanidine derivative treats bacterial infections in farmed animals

USPTO granted patent US12589085B2 to Guangzhou Insighter Biotechnology Co., Ltd. for a diaminoguanidine derivative compound and feed composition for veterinary use in preventing and treating bacterial infections in farmed animals. The patent covers the compound with R1 as C1-C20 alkyl, applications including reproductive system and skin infections, and includes 11 claims.

Vehicular crime mitigation system using blockchain and cryptography

USPTO granted US Patent 12589712B2 to JGR Software Group LLC on March 31, 2026, covering a vehicular crime mitigation system that uses blockchain and cryptography. The patent describes technologies for monitoring vehicles, detecting anomalous activity, and recording trip information on a blockchain.

Function selection in industrial networks

USPTO granted patent US12591222B2 to Cisco Technology, Inc. covering methods for selecting 5G user plane functions in industrial networks based on hierarchical security model layers. The patent, filed April 24, 2023, includes 20 claims related to associating 5G functions with contextual security information and directing endpoint communications accordingly.

Anomaly detection and protection

The USPTO granted Patent US12591002B2 to ZERO-ERROR SYSTEMS PTE. LTD. covering an apparatus and method for detecting anomalies in electronic systems with integrated circuits. The patent describes sensing current and voltage characteristics of supply rails to identify anomalies and enable removal or mitigation. The patent contains 19 claims and has 4 named inventors.

Production of antibodies by modification of autonomous heavy chain variable domain via gene conversion

USPTO granted patent US12588664B2 to Crystal Bioscience Inc. on March 31, 2026. The patent covers transgenic animals engineered with B cells that use gene conversion for antibody diversification, involving functional immunoglobulin heavy chain genes and operably linked pseudogenes that donate sequence to enable diversification.

Cerebrolysin patent for CADASIL treatment

USPTO granted patent US12589118B2 to Ever Neuro Pharma GmbH for a method of using cerebrolysin to reduce mortality in patients with CADASIL (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy). The patent includes 15 claims and was filed on August 28, 2018.

Method for producing modified pea protein

USPTO granted patent US12588686B2 to Ajinomoto Co., Inc. covering methods for producing modified pea protein with improved solubility. The method involves treating pea ground product with acid and conducting enzyme reactions using protein deamidase. The patent contains 4 claims and names three inventors.

177Lu peptide targets uPAR receptor for colorectal cancer treatment

USPTO granted patent US12589171B2 to TRT INNOVATIONS APS covering a 177-Lu labeled peptide for site-specific targeting of the Urokinase Plasminogen Activator Receptor (uPAR) for treatment of cancers with high uPAR expression, particularly colorectal cancer. The patent includes 9 claims and lists inventors Andreas Kjaer, Morten Persson, and Michael Ploug.

CD80 Extracellular Domain Fc Fusion Proteins for Treating PD-L1 Negative Tumors

The USPTO granted Patent US12589132B2 to Five Prime Therapeutics, Inc. covering fusion proteins combining the CD80 extracellular domain with the Fc domain of IgG1 for treating PD-L1 negative tumors. The patent includes 22 claims and names Susannah D. Barbee, Thomas Brennan, and Barbara Sennino as inventors. This grant establishes exclusive rights for the assignee in this therapeutic application.

Root-knot Nematode Resistance Gene Patent Grant

USPTO granted patent US12588644B2 to Rijk Zwaan Zaadteelt En Zaadhandel B.V. covering a nucleic acid encoding the MeR1 protein that confers resistance to root-knot nematode in Solanaceae plants. The patent includes 18 claims covering the gene sequences, amino acid sequences, and methods of using the resistance gene in plant breeding. The inventors are Raoul Jacobus Johannes Maria Frijters, Jonathan Kalisvaart, and Adriaan Verhage.

Otoferlin Dual Vector Systems for Treating Sensorineural Hearing Loss

The USPTO granted Regeneron Pharmaceuticals Patent US12589168B2 for compositions and methods treating sensorineural hearing loss using otoferlin (OTOF) dual vector gene therapy systems. The patent covers a two-vector approach delivering N-terminal and C-terminal portions of OTOF isoform 5 to restore gene function in patients with OTOF mutations. Application No. 17733744 was filed April 29, 2022.

Process for the production of levetiracetam

USPTO granted Patent US12590059B2 to Suzhou BrightHope Pharmatech Co., Ltd. for a process to produce levetiracetam via crystallization in aqueous solution, resulting in a product containing no residual organic solvent. The patent lists 4 inventors (Songzhou Hu, Lijun Deng, Wen Yu, Zhen Song) and contains 13 claims under classification C07D 207/27.

Levorphanol prodrugs and processes for making and using them

The USPTO granted Patent US12590065B2 to Zevra Therapeutics, Inc. covering novel levorphanol prodrug compositions formed by chemically conjugating oxoacids, polyethylene glycols, or vitamin compounds to levorphanol. The patent includes claims to the compositions and methods of making and using them.

Fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds and use thereof

USPTO granted Patent US12590066B2 to Korea Institute of Science and Technology for novel fused-heterocyclyl-carbonohydrazonoyl dicyanide compounds. The patent includes 20 claims and names inventors Ae Nim Pae, Yun Kyung Kim, Sang Min Lim, Sungsu Lim, Haeun Lee, Woo Seung Son, and Hye Yeon Lee. The compounds have potential pharmaceutical applications.